Real-time enrollment status for this eosinophilic granulomatosis with polyangiitis clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 9:24 PM UTC
| NCT Number | NCT06046222 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Eosinophilic Granulomatosis With Polyangiitis |
| Phase | Clinical Trial |
| Target Enrollment | 45 participants |
| Active Locations | 7 sites in the US |
| Sponsor | NS Pharma, Inc. |
| Last Updated on CT.gov | May 26, 2026 (6 days ago) |
As of June 1, 2026: Clinical trial NCT06046222 is currently active_not_recruiting participants. This clinical trial study for eosinophilic granulomatosis with polyangiitis is not currently accepting new participants at 7 locations across the United States. The study is sponsored by NS Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06046222 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06046222 was last updated 6 days ago (May 26, 2026). HelloStudys verifies this status automatically.